8K7 — UG Healthcare Income Statement
0.000.00%
Last trade - 00:00
- SG$68.62m
- SG$51.33m
- SG$101.13m
- 18
- 54
- 64
- 40
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 91.7 | 144 | 338 | 233 | 101 |
Cost of Revenue | |||||
Gross Profit | 18.7 | 42.5 | 196 | 84.4 | 1.45 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 88 | 125 | 182 | 183 | 129 |
Operating Profit | 3.67 | 18.9 | 156 | 49.5 | -28 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2.76 | 18.1 | 159 | 48.8 | -28.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.22 | 15.1 | 120 | 39.8 | -27 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.51 | 13.4 | 119 | 36.8 | -20.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.51 | 13.4 | 119 | 36.8 | -20.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.004 | 0.023 | 0.195 | 0.06 | -0.028 |
Dividends per Share | |||||
Special Dividends per Share |